Monday, January 3, 2022

FDA Approves Pfizer Booster For 12-15 Year Olds, Dismisses Risk Of "Mild" Heart Inflammation

 As expected, the FDA has finally approved Pfizer's COVID booster for children between the ages of 12 and 15, despite the fact that certain dangerous side effects are far more likely to occur in young patients.

These dangerous side effects include myocarditis and pericarditis, two forms of heart inflammation that have been found in thousands of patients and have even contributed to some suspicious vaccine-linked deaths.